$ARDX
ARDELYX, INC.

2023 Q4 Form 10-Q Financial Statement

#000162828023035597 Filed on October 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $34.36M $56.39M
YoY Change -22.22% 1030.99%
Cost Of Revenue $5.077M $7.692M
YoY Change 60.56% 950.82%
Gross Profit $29.29M $48.70M
YoY Change -28.6% 1044.78%
Gross Profit Margin 85.23% 86.36%
Selling, General & Admin $47.75M $32.66M
YoY Change 141.99% 74.98%
% of Gross Profit 163.04% 67.07%
Research & Development $9.524M $8.637M
YoY Change 4.18% 15.67%
% of Gross Profit 32.52% 17.74%
Depreciation & Amortization $362.0K $290.0K
YoY Change 232.11% -53.82%
% of Gross Profit 1.24% 0.6%
Operating Expenses $57.27M $41.30M
YoY Change 98.36% 58.04%
Operating Profit -$27.99M $7.398M
YoY Change -330.47% -133.81%
Interest Expense -$1.740M $1.107M
YoY Change 75.58% 24.94%
% of Operating Profit 14.96%
Other Income/Expense, Net $1.257M $1.460M
YoY Change -375.05% 107.39%
Pretax Income -$28.47M $6.829M
YoY Change -366.19% -129.83%
Income Tax $333.0K $200.0K
% Of Pretax Income 2.93%
Net Earnings -$28.80M $6.629M
YoY Change -369.3% -128.96%
Net Earnings / Revenue -83.82% 11.76%
Basic Earnings Per Share $0.03
Diluted Earnings Per Share -$0.12 $0.03
COMMON SHARES
Basic Shares Outstanding 232.1M shares 217.9M shares
Diluted Shares Outstanding 227.9M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $184.3M $165.1M
YoY Change 48.74% 82.16%
Cash & Equivalents $21.47M $33.77M
Short-Term Investments $162.8M $131.3M
Other Short-Term Assets $27.33M $24.30M
YoY Change 46.33% 6.61%
Inventory $49.49M $47.50M
Prepaid Expenses
Receivables $22.03M $43.26M
Other Receivables $0.00 $0.00
Total Short-Term Assets $246.1M $241.2M
YoY Change 60.23% 101.22%
LONG-TERM ASSETS
Property, Plant & Equipment $1.009M $1.116M
YoY Change -17.5% -13.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.596M $1.550M
YoY Change 308.17% -88.36%
Total Long-Term Assets $51.47M $48.16M
YoY Change 41.15% 94.23%
TOTAL ASSETS
Total Short-Term Assets $246.1M $241.2M
Total Long-Term Assets $51.47M $48.16M
Total Assets $297.6M $289.4M
YoY Change 56.57% 100.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.14M $7.736M
YoY Change 2.57% 148.51%
Accrued Expenses $30.03M $31.70M
YoY Change 41.12% 73.28%
Deferred Revenue $7.182M $4.072M
YoY Change 70.55% 1.72%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $50.39M $43.53M
YoY Change -23.18% -16.21%
LONG-TERM LIABILITIES
Long-Term Debt $49.82M $27.20M
YoY Change
Other Long-Term Liabilities $30.55M $170.0K
YoY Change 16.89% -99.34%
Total Long-Term Liabilities $80.37M $170.0K
YoY Change 207.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.39M $43.53M
Total Long-Term Liabilities $80.37M $170.0K
Total Liabilities $130.8M $98.22M
YoY Change 42.54% 26.23%
SHAREHOLDERS EQUITY
Retained Earnings -$846.2M -$817.4M
YoY Change 8.47% 3.36%
Common Stock $1.013B $1.009B
YoY Change 15.28% 17.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.8M $191.2M
YoY Change
Total Liabilities & Shareholders Equity $297.6M $289.4M
YoY Change 56.57% 100.02%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$28.80M $6.629M
YoY Change -369.3% -128.96%
Depreciation, Depletion And Amortization $362.0K $290.0K
YoY Change 232.11% -53.82%
Cash From Operating Activities -$8.717M -$21.47M
YoY Change -161.03% -15.56%
INVESTING ACTIVITIES
Capital Expenditures $44.00K $190.0K
YoY Change -20.0%
Acquisitions
YoY Change
Other Investing Activities -$29.52M -$32.50M
YoY Change -2073.53% 3806.25%
Cash From Investing Activities -$29.57M -$32.70M
YoY Change -2151.91% 3830.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.98M 57.88M
YoY Change 38.31% 67.87%
NET CHANGE
Cash From Operating Activities -8.717M -21.47M
Cash From Investing Activities -29.57M -32.70M
Cash From Financing Activities 25.98M 57.88M
Net Change In Cash -12.30M 3.710M
YoY Change -135.64% -54.87%
FREE CASH FLOW
Cash From Operating Activities -$8.717M -$21.47M
Capital Expenditures $44.00K $190.0K
Free Cash Flow -$8.761M -$21.66M
YoY Change -161.57% -14.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6523000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9295000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1116000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1223000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1550000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
881000 usd
CY2023Q3 us-gaap Assets
Assets
289379000 usd
CY2022Q4 us-gaap Assets
Assets
190066000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7736000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10859000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8357000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7548000 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
26711000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56391000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4986000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
170000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q3 us-gaap Liabilities
Liabilities
98218000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
91737000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
232133132 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
232133132 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
198575016 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
198575016 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
23000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
20000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1008741000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
878500000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-817402000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-780137000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-201000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-54000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
191161000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
98329000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
289379000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
190066000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90093000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7980000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7692000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
732000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12718000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
955000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8637000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7467000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26012000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26059000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32664000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18667000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86653000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56868000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
41301000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
26134000 usd
us-gaap Costs And Expenses
CostsAndExpenses
112665000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7398000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21880000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1107000 usd
us-gaap Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
841000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4308000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1258000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22893000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37051000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77894000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
214000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22893000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77902000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222782229 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165104789 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214976555 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147319818 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
227894335 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165104789 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214976555 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147319818 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22893000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77902000 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-147000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-108000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6638000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22898000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37412000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78010000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
670000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57163000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3489000 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
191161000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
98329000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
808000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
337000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
251000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
119248000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9600000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-147000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
191161000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
53042000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
112000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
390000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34367000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1848000 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22893000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
66861000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
82617000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
195000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
390000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
52845000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8824000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-108000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77902000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
66861000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77902000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
930000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1017000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2690000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2570000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8824000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1260000 usd
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
27229000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4715000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3093000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1055000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1483000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-174000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35530000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4706000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19152000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9774000 usd
ardx Increase Decrease In Prepaid Commercial Manufacturing Expense
IncreaseDecreaseInPrepaidCommercialManufacturingExpense
3609000 usd
ardx Increase Decrease In Prepaid Commercial Manufacturing Expense
IncreaseDecreaseInPrepaidCommercialManufacturingExpense
10549000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2671000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-754000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3123000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1164000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
809000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1743000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2880000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2571000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6466000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-375000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1126000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7836000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80999000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-84328000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
36264000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
59000000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
137644000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
43824000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1798000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
301000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101681000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16974000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
26971000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
33038000 usd
ardx Proceeds From Sale Of Future Royalties Net Of Issuance Costs
ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts
0 usd
ardx Proceeds From Sale Of Future Royalties Net Of Issuance Costs
ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts
9581000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
119248000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52845000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1059000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
195000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120307000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56554000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62373000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10800000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96140000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72428000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33767000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61628000 usd
us-gaap Interest Paid Net
InterestPaidNet
2692000 usd
us-gaap Interest Paid Net
InterestPaidNet
2079000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
339000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Stock Issued1
StockIssued1
337000 usd
us-gaap Stock Issued1
StockIssued1
390000 usd
ardx Derivative Issued
DerivativeIssued
0 usd
ardx Derivative Issued
DerivativeIssued
375000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes thereto. On an ongoing basis, management evaluates its estimates, including those related to recognition of revenue, clinical trial accruals, contract manufacturing accruals, utilization of inventory, fair value of assets and liabilities, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could materially differ from those estimates.</span></div>
CY2023Q3 us-gaap Investments And Cash
InvestmentsAndCash
165100000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-817400000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33767000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33767000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
131514000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
207000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
131313000 usd
CY2023Q3 ardx Investments And Cash Amortized Cost
InvestmentsAndCashAmortizedCost
165281000 usd
CY2023Q3 ardx Cash Cash Equivalents And Investments Gross Unrealized Gains
CashCashEquivalentsAndInvestmentsGrossUnrealizedGains
6000 usd
CY2023Q3 ardx Cash Cash Equivalents And Investments Gross Unrealized Losses
CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses
207000 usd
CY2023Q3 us-gaap Investments And Cash
InvestmentsAndCash
165080000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96140000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96140000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
27823000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
60000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
27769000 usd
CY2022Q4 ardx Investments And Cash Amortized Cost
InvestmentsAndCashAmortizedCost
123963000 usd
CY2022Q4 ardx Cash Cash Equivalents And Investments Gross Unrealized Gains
CashCashEquivalentsAndInvestmentsGrossUnrealizedGains
6000 usd
CY2022Q4 ardx Cash Cash Equivalents And Investments Gross Unrealized Losses
CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses
60000 usd
CY2022Q4 us-gaap Investments And Cash
InvestmentsAndCash
123909000 usd
CY2022 ardx Available For Sale Securities Debt Securities Current Contractual Maturities Maximum
AvailableForSaleSecuritiesDebtSecuritiesCurrentContractualMaturitiesMaximum
P1Y
ardx Available For Sale Securities Debt Securities Current Contractual Maturities Maximum
AvailableForSaleSecuritiesDebtSecuritiesCurrentContractualMaturitiesMaximum
P1Y
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
0 investment
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
0 investment
CY2022Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
22783000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
22299000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
22956000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5324000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1759000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
723000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
47498000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
28346000 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
8524000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
3282000 usd
CY2023Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
38974000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
25064000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
47498000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
28346000 usd
CY2023Q3 ardx Prepaid Commercial Manufacturing Current
PrepaidCommercialManufacturingCurrent
17200000 usd
CY2022Q4 ardx Prepaid Commercial Manufacturing Current
PrepaidCommercialManufacturingCurrent
13600000 usd
CY2022Q4 ardx Contract With Customer Gross To Net Sales Accruals
ContractWithCustomerGrossToNetSalesAccruals
2844000 usd
ardx Contract With Customer Gross To Net Sales Provisions
ContractWithCustomerGrossToNetSalesProvisions
20817000 usd
ardx Contract With Customer Gross To Credits Or Deductions Issued
ContractWithCustomerGrossToCreditsOrDeductionsIssued
-16937000 usd
CY2023Q3 ardx Contract With Customer Gross To Net Sales Accruals
ContractWithCustomerGrossToNetSalesAccruals
6724000 usd
CY2023Q3 us-gaap Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
900000 usd
us-gaap Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
2900000 usd
CY2022Q3 us-gaap Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
800000 usd
us-gaap Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
800000 usd
us-gaap Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
0 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
28861000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1277000 usd
CY2023Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
355000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
27229000 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1450000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
329000 usd
CY2023Q3 ardx Lessee Operating Lease Liability To Be Paid After Year Three
LesseeOperatingLeaseLiabilityToBePaidAfterYearThree
0 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6523000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9295000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4321000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3894000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2887000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5855000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7208000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
9749000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.068
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.068
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1061000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1064000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3127000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3192000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1119000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1072000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3316000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3194000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1165000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.46
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7659000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
451000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7208000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4321000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2887000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3489000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1834000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8659000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13963000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7512000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.94
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
127000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
144000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.45
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21204000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.18
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11209000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22893000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77902000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222782000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165105000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214977000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147320000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
227894000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165105000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214977000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147320000 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15183000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15604000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23790000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16724000 shares
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001628280-23-035597-index-headers.html Edgar Link pending
0001628280-23-035597-index.html Edgar Link pending
0001628280-23-035597.txt Edgar Link pending
0001628280-23-035597-xbrl.zip Edgar Link pending
ardx-20230930.htm Edgar Link pending
ardx-20230930.xsd Edgar Link pending
ardx-20230930xex311.htm Edgar Link pending
ardx-20230930xex312.htm Edgar Link pending
ardx-20230930xex321.htm Edgar Link pending
ardx-20230930_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
ardx-20230930_cal.xml Edgar Link unprocessable
ardx-20230930_def.xml Edgar Link unprocessable
ardx-20230930_lab.xml Edgar Link unprocessable
ardx-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ardx-20230930_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending